tiprankstipranks
Advertisement
Advertisement

MAZE Stock Latest News

Legal and Regulatory Risks Threaten Maze Therapeutics’ Funding, Reputation and Path to Commercialization
Company AnnouncementsLegal and Regulatory Risks Threaten Maze Therapeutics’ Funding, Reputation and Path to Commercialization
54m ago
MAZE
Maze Therapeutics: Buy Rating Reaffirmed as Clinical De-Risking Supports Unchanged $110 Price Target
PremiumRatings
Maze Therapeutics: Buy Rating Reaffirmed as Clinical De-Risking Supports Unchanged $110 Price Target
20h ago
MAZE
Maze Therapeutics: Buy Rating Reiterated on Strong Cash Runway and Advancing APOL1/PKU Programs; Price Target Maintained at $57
PremiumRatings
Maze Therapeutics: Buy Rating Reiterated on Strong Cash Runway and Advancing APOL1/PKU Programs; Price Target Maintained at $57
20h ago
MAZE
Maze Therapeutics reports Q2 EPS (76c), consensus (70c)
PremiumThe Fly
Maze Therapeutics reports Q2 EPS (76c), consensus (70c)
1d ago
MAZE
Maze Therapeutics Advances MZE782 Phase 2 PKU Trial, Setting Up a New Catalyst for MAZE Investors
PremiumCompany Announcements
Maze Therapeutics Advances MZE782 Phase 2 PKU Trial, Setting Up a New Catalyst for MAZE Investors
30d ago
MAZE
Analyst Reaffirms Buy on Maze with Unchanged $110 Price Target, Citing Strong HORIZON Data and Favorable Risk-Reward
PremiumRatingsAnalyst Reaffirms Buy on Maze with Unchanged $110 Price Target, Citing Strong HORIZON Data and Favorable Risk-Reward
2M ago
MAZE
Maze Therapeutics Shareholders Elect Directors, Ratify Auditor
Premium
Company Announcements
Maze Therapeutics Shareholders Elect Directors, Ratify Auditor
2M ago
8K
MAZE
Maze Therapeutics CFO Expands Role Amid Finance Leadership Change
Premium
Company Announcements
Maze Therapeutics CFO Expands Role Amid Finance Leadership Change
3M ago
8K
MAZE
MAZE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
MAZE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
MAZE
Maze Therapeutics: Buy Rating Reiterated, $57 Price Target Maintained on Strong Balance Sheet and Advancing Kidney Disease Pipeline
PremiumRatings
Maze Therapeutics: Buy Rating Reiterated, $57 Price Target Maintained on Strong Balance Sheet and Advancing Kidney Disease Pipeline
3M ago
MAZE
Maze Therapeutics reports Q1 EPS (45c), consensus (63c)
PremiumThe Fly
Maze Therapeutics reports Q1 EPS (45c), consensus (63c)
3M ago
MAZE
Maze Therapeutics prices $150 million equity offering
PremiumCompany Announcements
Maze Therapeutics prices $150 million equity offering
4M ago
8K
MAZE
Maze Therapeutics priced offering of 5.54M shares of common stock at $23.50
PremiumThe FlyMaze Therapeutics priced offering of 5.54M shares of common stock at $23.50
4M ago
MAZE
Maze Therapeutics price target lowered to $64 from $68 at Truist
Premium
The Fly
Maze Therapeutics price target lowered to $64 from $68 at Truist
4M ago
MAZE
MAZE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
MAZE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
MAZE
Maze Therapeutics price target raised to $58 from $52 at JPMorgan
PremiumThe Fly
Maze Therapeutics price target raised to $58 from $52 at JPMorgan
4M ago
MAZE
Encouraging HORIZON Phase 2 Data and Favorable Safety Support Buy Rating on Maze’s APOL1 Inhibitor MZE829
PremiumRatings
Encouraging HORIZON Phase 2 Data and Favorable Safety Support Buy Rating on Maze’s APOL1 Inhibitor MZE829
5M ago
MAZE
Midday Fly By: Merck to acquire Terns, Arm CPU launch applauded
PremiumThe Fly
Midday Fly By: Merck to acquire Terns, Arm CPU launch applauded
5M ago
GM
AMD
Maze Therapeutics falls -29.8%
PremiumThe Fly
Maze Therapeutics falls -29.8%
5M ago
MAZE
Maze Therapeutics share sell-off an ‘overreaction,’ says Raymond James
PremiumThe FlyMaze Therapeutics share sell-off an ‘overreaction,’ says Raymond James
5M ago
MAZE
VRTX
Maze Therapeutics falls -33.2%
Premium
The Fly
Maze Therapeutics falls -33.2%
5M ago
MAZE
Leerink remains bullish on Maze, says Vertex comparison ‘apples to oranges’
Premium
The Fly
Leerink remains bullish on Maze, says Vertex comparison ‘apples to oranges’
5M ago
MAZE
VRTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >